Andy Itsara, Victoria M. Rogness, Laura Samples, Constance M. Yuan, Hao-Wei Wang, Inhye E. Ahn, Mohammed Z. H. Farooqui, Xin Tian, Clare Sun, Emily Tomasulo, Susan Soto, Jeanine Superata, Larisa Bezkorovaynaya, Thomas E. Hughes, Pia Nierman, Adrian Wiestner. "A decade of ibrutinib for CLL with and without
                    <i>TP53</i>
                    aberration: final report on an investigator-sponsored phase 2 study." Blood, 2026. doi:10.1182/blood.2025029971